Dimensional Fund Advisors’s Perspective Therapeutics CATX Stock Holding History

Dimensional Fund Advisors’s Portfolio CATX Stock Details CATX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.66M	Buy	1,074,071 +623,974	+139%	+$2.36M	﹤0.01%	2610
2026 Q1	$1.88M	Buy	450,097 +358,540	+392%	+$1.51M	﹤0.01%	2718
2025 Q4	$252K	Buy	+91,557	New	+$261K	﹤0.01%	3065
2014 Q4	–	Sell	-1,302	Closed	-$22K	–	3513
2014 Q3	$22K	Hold	1,302	–	–	﹤0.01%	3440
2014 Q2	$41K	Hold	1,302	–	–	﹤0.01%	3451
2014 Q1	$29K	Hold	1,302	–	–	﹤0.01%	3491
2013 Q4	$7K	Hold	1,302	–	–	﹤0.01%	3508
2013 Q3	$8K	Sell	1,302 -40	-3%	-$250	﹤0.01%	3537
2013 Q2	$6K	Buy	+1,342	New	+$7.24K	﹤0.01%	3541

Other funds holding CATX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AAA

Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

SSC

Spruce Street Capital New York $510M AUM

Dimensional Fund Advisors's CATX Position: Q2 2026 in Review

Dimensional Fund Advisors increased its Perspective Therapeutics (CATX) stake by 139% in Q2 2026, buying an estimated $2.36M and bringing the position to 1,074,071 shares worth $3.66M. The position accounts for ﹤0.01% of the portfolio, ranked #2610.

Dimensional Fund Advisors first reported a position in CATX in Q2 2013 and has held it in 9 quarters since. 132 funds tracked by Wall St. Rank hold CATX as of Q2 2026.

Dimensional Fund Advisors held 1,074,071 shares of Perspective Therapeutics worth $3.66M as of Q2 2026.
Dimensional Fund Advisors bought 623,974 Perspective Therapeutics shares in Q2 2026, an estimated $2.36M.
Perspective Therapeutics made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q2 2026, its #2610 holding.
Dimensional Fund Advisors first reported a position in Perspective Therapeutics in Q2 2013 and has held it in 9 quarters since.
132 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q2 2026.

Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.